Go Deep
Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,430 | -0.3 | 7.93 | 0.01 | 527.56 |
| Oct 2026 | 19,834 | -0.3 | 7.23 | 0.01 | 481.15 |
| Oct 2026 | 18,131 | -0.3 | 6.72 | 0.01 | 447.53 |
| Oct 2026 | 17,975 | -0.3 | 6.99 | 0.01 | 465.55 |
| Oct 2026 | 18,049 | -0.3 | 6.86 | 0.01 | 455.89 |
| Oct 2026 | 18,222 | -0.3 | 6.56 | 0.01 | 435.14 |
Shuttle Pharmaceuticals Holdings, Inc. Quarterly Results
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -2,152,471.0 | -2,614,895.0 | -2,347,302.0 | -3,706,465.0 |
| EPS | -4.3 | — | -10.5 | -32.9 |
Shuttle Pharmaceuticals Holdings, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -11,721,669.0 | -9,144,797.0 | -6,592,723.0 | -4,996,069.0 | — |
| EPS | -71.6 | -796.5 | -882.5 | -1,260.0 | — |
Shuttle Pharmaceuticals Holdings, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 10,475,977.0 | 2,506,290.0 | 5,951,736.0 | 8,653,545.0 | — |
| Total Liabilities | 8,221,531.0 | 1,797,138.0 | 1,895,965.0 | 975,676.0 | — |
| Total Equity | 2,254,446.0 | 709,152.0 | 4,055,771.0 | 7,677,869.0 | — |
Owes vs Owns
Shuttle Pharmaceuticals Holdings, Inc. owed $0.72 for every $1 it owned in Mar 2026, up from $0.11 in Dec 2022.
| Period | Mar 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.72× | 0.78× | 0.72× | 0.32× | 0.11× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Shuttle Pharmaceuticals Holdings, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 3.2%Fixed assets (tangible) 1.1%Intangible assets 93.9%Other assets 1.7%
How it's funded — Dec 2025
Short-term debt 0.7%Long-term debt 1.5%Payables 13.9%Other liabilities 62.4%Shareholders' equity 21.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.3 | 1.9 | 5.5 | 8.4 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.1 | 0.3 | 0.4 | 0.1 |
| Intangible assets | 9.8 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.2 | 0.3 | 0.1 | 0.2 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.9 | 0.6 | 0.7 |
| Long-term debt | 0.2 | 0.2 | 0.1 | 0.0 |
| Payables | 1.5 | 0.6 | 0.3 | 0.1 |
| Other liabilities | 6.5 | 0.1 | 0.9 | 0.2 |
| Shareholders' equity | 2.3 | 0.7 | 4.1 | 7.7 |
| Net tangible assets | -7.6 | 0.7 | 4.1 | 7.7 |
Shuttle Pharmaceuticals Holdings, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -9,481,645.0 | -7,327,230.0 | -5,581,147.0 | -2,666,411.0 | — |
| Investing Activities | -3,056,722.0 | 2,915,765.0 | -2,829,723.0 | 0.0 | — |
| Financing Activities | 10,952,228.0 | 3,755,193.0 | 2,570,083.0 | 10,578,865.0 | — |